Form 4 · Filed Jun 22, 2026, 08:14 PM UTC
NAUT/Nautilus Biotechnology, Inc.
NAZEM FARZAD — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | A | other | 45,000 | — | — | 45,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001234663-26-000002